Position in RLAY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$20,115,607
+$19,745,018 QoQ
Shares Held
1,075,126
+1095.3% QoQ
Ownership
0.491%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#41
of 256 holders
Holding Since
Jun 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. RLAY ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in RLAY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,115,607 | 1,075,126 | Shares | Sole | 2026-08-11 | |
| 2024-12-31 | $370,589 | 89,949 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $984,745 | 118,644 | Shares | Sole | 2024-05-13 | |
| 2022-12-31 | $197,715 | 13,234 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,507,670 | 67,397 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $240,915 | 14,383 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||